IPQ Inside the global regulatory dialogue

Emergency Preparations Draw Heightened Industry and Regulator Attention as Natural and Man-Made Disasters Proliferate

Dec 27th, 2018

Please Log in to print the full article

Extreme weather events, political instability, and economic disruptions are prompting the pharmaceutical community to heighten its focus on emergency preparedness. The following four-part report focuses on conference presentations and discussions during 2018 that have made a significant contribution to understanding the increasing challenges that industry and regulators are now facing around the world and how they are being addressed.

PART I: Complementary strategies developed by Biogen and Baxter for supply chain control and disaster preparation

PART II: FDA’s role and actions taken in responding to Hurricane Maria and other recent natural disasters

PART III: The increased risks from climatic, societal, and political disruptions around the world and the planning they are informing from an internationally recognized author and advisor

PART IV: An expert panel discussion on the human impacts and other considerations of the natural and manmade disasters

 [The story continues for subscribers on p. 2.  Nonsubscribers can get information on individual IPQ subscriptions and organization-wide licenses by contacting Peter Blachly ([email protected]).]

Pages: 1 2

    ©2021 IPQ Publications